Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
作者： David Cunningham , Seppo Pyrhönen , Roger D James , Cornelis JA Punt , Tamas F Hickish
DOI: 10.1016/S0140-6736(98)02309-5
关键词:
摘要: … C Jacques managed the study, data documentation, and the writing of the study report. PH and DC prepared the first draft of the manuscript to which everyone then contributed. …
openrepository.com
elsevier.com
sci-hub.se 参考文章(15)
H C Pitot, D B Wender, M J O'Connell, G Schroeder, R M Goldberg, J Rubin, J A Mailliard, J A Knost, C Ghosh, R J Kirschling, R Levitt, H E Windschitl, Phase II Trial of Irinotecan in Patients With Metastatic Colorectal Carcinoma Journal of Clinical Oncology. ,vol. 15, pp. 2910- 2919 ,(1997) , 10.1200/JCO.1997.15.8.2910
Steven A. Rosenberg, Vincent T. DeVita, Samuel Hellman, Cancer : Principles and Practice of Oncology ,(1982)
P Rougier, R Bugat, J Y Douillard, S Culine, E Suc, P Brunet, Y Becouarn, M Ychou, M Marty, J M Extra, J Bonneterre, A Adenis, J F Seitz, G Ganem, M Namer, T Conroy, S Negrier, Y Merrouche, F Burki, M Mousseau, P Herait, M Mahjoubi, Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 251- 260 ,(1997) , 10.1200/JCO.1997.15.1.251
M L Rothenberg, J R Eckardt, J G Kuhn, H A Burris, J Nelson, S G Hilsenbeck, G I Rodriguez, A M Thurman, L S Smith, S G Eckhardt, G R Weiss, G L Elfring, D A Rinaldi, L J Schaaf, D D Von Hoff, Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. Journal of Clinical Oncology. ,vol. 14, pp. 1128- 1135 ,(1996) , 10.1200/JCO.1996.14.4.1128
S Earlam, C Glover, C Fordy, D Burke, T G Allen-Mersh, Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. Journal of Clinical Oncology. ,vol. 14, pp. 171- 175 ,(1996) , 10.1200/JCO.1996.14.1.171
W Scheithauer, H Rosen, G V Kornek, C Sebesta, D Depisch, Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. ,vol. 306, pp. 752- 755 ,(1993) , 10.1136/BMJ.306.6880.752
Bengt Glimelius, Katarina Hoffman, Wilhelm Graf, Lars Påhlman, Per-Olow Sjödén, , Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer Cancer. ,vol. 73, pp. 556- 562 ,(1994) , 10.1002/1097-0142(19940201)73:3<556::AID-CNCR2820730310>3.0.CO;2-8
N. Kemeny, D. Niedzwiecki, B. Shurgot, P. Oderman, Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer. ,vol. 63, pp. 742- 747 ,(1989) , 10.1002/1097-0142(19890215)63:4<742::AID-CNCR2820630423>3.0.CO;2-T
Ph. Rougier, C. Milan, F. Lazorthes, G. Fourtanier, C. Partensky, H. Baumel, J. Faivre, Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer British Journal of Surgery. ,vol. 82, pp. 1397- 1400 ,(2005) , 10.1002/BJS.1800821034
G.J. Creemers, B. Lund, J. Verweij, Topoisomerase I inhibitors: topotecan and irenotecan Cancer Treatment Reviews. ,vol. 20, pp. 73- 96 ,(1994) , 10.1016/0305-7372(94)90011-6